Skip to Main Content

Search Results

Listed below are the search results that match your search criteria. Select the document title to view the details page for the specific record. You can also select items using their corresponding check boxes in the right column. After selecting the check boxes you can print the selected items or add them to your basket by selecting the 'Print Selected' or 'Add to Basket' buttons.

MCD ARCHIVE

Document Update Schedule
Local Coverage Documents (LCDs and Articles) move from the CMS Medicare Coverage Database (MCD) to the MCD Archive in real-time, according to the following schedule:

  • Proposed/Draft LCDs move to the MCD Archive 90 days after being released to the final LCD.
  • Retired LCDs and Articles move to the MCD Archive 90 days after their retirement dates.
  • Superseded versions of active LCDs and Articles move to the MCD Archive after 1 year.
  • All LMRPs reside on the MCD Archive.

Please visit the MCD Archive Site to view archived documents.

Your Search Results

[742 Records]
National Coverage Determinations (NCDs)
Page 1 of 14
FirstPrev123456...NextLast
NCD Section
NCD Title
100.324-Hour Ambulatory Esophageal pH Monitoring
110.19Abarelix for the Treatment of Prostate Cancer
140.1Abortion
30.3Acupuncture
30.3.1Acupuncture for Fibromyalgia
30.3.2Acupuncture for Osteoarthritis
260.1Adult Liver Transplantation
280.8Air-Fluidized Bed
190.25Alpha-fetoprotein
20.19Ambulatory Blood Pressure Monitoring
160.22Ambulatory EEG Monitoring
10.6Anesthesia in Cardiac Pacemaker Surgery
110.17Anti-Cancer Chemotherapy for Colorectal Cancer
110.9Antigens Prepared for Sublingual Administration
110.3Anti-Inhibitor Coagulant Complex (AICC)
110.14Apheresis (Therapeutic Pheresis)
110.18Aprepitant for Chemotherapy-Induced Emesis
150.9Arthroscopic Lavage and Arthroscopic Debridement for the Osteoarthritic Knee
20.9Artificial Hearts and Related Devices
160.7.1Assessing Patient's Suitability for Electrical Nerve Stimulation Therapy
10.5Autogenous Epidural Blood Graft
110.22Autologous Cellular Immunotherapy Treatment
100.1Bariatric Surgery for Treatment of Morbid Obesity
220.6.20Beta Amyloid Positron Tomography in Dementia and Neurodegenerative Disease
30.1Biofeedback Therapy
Page 1 of 14
FirstPrev123456...NextLast
National Coverage Analyses (NCAs)
Page 1 of 9
FirstPrev1234567...NextLast
NCA Tracking #
NCA Title
Review Status
Review Type
CAG-00238N Abarelix for the Treatment of Prostate Cancer Closed New
CAG-00049N Actinic Keratoses Closed New
CAG-00174N Acupuncture for Fibromyalgia Closed New
CAG-00062N Acupuncture for Nausea after Chemotherapy and Post-operative Pain Closed New
CAG-00175N Acupuncture for Osteoarthritis Closed New
CAG-00017R Air-Fluidized Beds for Pressure Ulcers Closed 1st Recon
CAG-00017N Air-Fluidized Beds for Pressure Ulcers Closed New
CAG-00415N Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Myelodysplastic Syndrome Closed New
CAG-00067R Ambulatory Blood Pressure Monitoring Closed 1st Recon
CAG-00067N Ambulatory Blood Pressure Monitoring Closed New
CAG-00179N Anticancer Chemotherapy for Colorectal Cancer Closed New
CAG-00248R Aprepitant for Chemotherapy-Induced Emesis Closed 1st Recon
CAG-00248N Aprepitant for Chemotherapy-Induced Emesis Closed New
CAG-00167N Arthroscopy for the Osteoarthritic Knee Closed New
CAG-00322N Artificial Hearts Closed New
CAG-00055N Augmentative and Alternative Communication (AAC) Devices for Speech Impairment Closed New
CAG-00190R2 Autologous Blood Derived Products for Chronic Non-Healing Wounds Closed 2nd Recon
CAG-00190R3 Autologous Blood-Derived Products for Chronic Non-Healing Wounds Closed 3rd Recon
CAG-00190N Autologous Blood-Derived Products for Chronic Non-Healing Wounds Closed New
CAG-00422N Autologous Cellular Immunotherapy Treatment of Metastatic Prostate Cancer Closed New
CAG-00050R Autologous Stem Cell Transplantation (AuSCT) for Amyloidosis Closed 1st Recon
CAG-00011R Autologous Stem Cell Transplantation (AuSCT) for Multiple Myeloma Closed 1st Recon
CAG-00011N Autologous Stem Cell Transplantation (AuSCT) for Multiple Myeloma Closed New
CAG-00050N Autologous Stem Cell Transplantation for AL Amyloidosis Closed New
CAG-00250R Bariatric Surgery for the Treatment of Morbid Obesity Closed 1st Recon
Page 1 of 9
FirstPrev1234567...NextLast
Coding Analyses for Labs (CALs)
Page 1 of 2
FirstPrev12NextLast
CAL Tracking #
CAL Title
Review Status
Review Type
CAG-00285N Blood Counts (Addition of ICD-9-CM Codes V77.1, V81.0, V81.1, and V81.2 to the list of Codes that Do Not Support Medical Necessity) Closed New
CAG-00182N Blood Counts (Revision of CPT Codes) Closed New
CAG-00183N Blood Glucose Testing (Revision of ICD-9-CM Codes for Osteomyelitis) Closed New
CAG-00297N Codes That Are Not Covered by Medicare (Removal of ICD-9-CM Code V76.44, Prostate Cancer Screening, From the List) Closed New
CAG-00298N Coding Guidelines for Urine Culture Closed New
CAG-00373N Glycated Hemoglobin/Glycated Protein (Addition of CPT Code 83037, Hemoglobin; glycosylated [A1c] by device cleared by FDA for home use) Closed New
CAG-00336N Glycated Hemoglobin/Glycated Protein (Addition of ICD-9-CM 271.3, Intestinal disaccharidase deficiencies and disaccharide malabsorption) Closed New
CAG-00283N Hepatitis Panel (Removal of ICD-9-CM Code 784.69, Other symbolic dysfunction, from the list of Codes Covered by Medicare) Closed New
CAG-00304N Hepatitis Panel/Acute Hepatitis Panel (Addition of ICD-9-CM 790.4, Elevation of Levels of Transaminase or Lactic Acid Dehydrogenase) Closed New
CAG-00335N Hepatitis Panel/Acute Hepatitis Panel (Addition of ICD-9-CM 790.5, Other nonspecific abnormal serum enzyme levels, as a covered indication) Closed New
CAG-00372N Human Chorionic Gonadotropin (Addition of ICD-9-CM Code 158.9, Malignant Neoplasm of Peritoneum, Unspecified) Closed New
CAG-00266N Lipid and Blood Glucose Testing (Modification of Code List to Implement Screening Benefit Added by Medicare Modernization Act (MMA) Closed New
CAG-00327N Partial Thromboplastin Time (Addition of ICD-9-CM 289.81, Primary Hypercoagulable State as a covered indication) Closed New
CAG-00338N Partial Thromboplastin Time (PTT) (Addition of ICD-9-CM V58.83, Encounter for therapeutic drug monitoring, as a covered indication) Closed New
CAG-00326N Prostate Specific Antigen (Addition of ICD-9-CM 600.00, Hypertrophy (benign) of Prostate Without Urinary Obstruction, as a covered indication) Closed New
CAG-00232N Prostate Specific Antigen (Inclusion of ICD-9-CM Code 600.01 for BPH with Urine Obstruction) Closed New
CAG-00328N Prothrombin Time (Addition of ICD-9-CM 289.81, Primary Hypercoagulable State as a Covered Indication) Closed New
CAG-00339N Prothrombin Time (PT) (Addition of ICD-9-CM V58.83, Encounter for therapeutic drug monitoring, as a covered indication) Closed New
CAG-00428N Prothrombin Time (PT) (Addition of two ICD-9-CM diagnosis codes) Closed New
CAG-00246N Prothrombin Time (PT) and Partial Thromboplastin Time (PTT) tests (Removal of Unspecified Joint Replacements) Closed New
CAG-00404N Prothrombin Time (PT) NCD 190.17 (Addition of ICD-9-CM diagnosis code 197.7 Secondary Malignant Neoplasm of Liver) Closed New
CAG-00187N Prothrombin Time and Fecal Occult Blood (Revision of ICD-9-CM Codes for Injury to Gastrointestinal Tract) Closed New
CAG-00184N Prothrombin Time and Partial Thromboplastin Time (Revision of ICD-9-CM Codes for Pre-operative Examinations) Closed New
CAG-00201N Prothrombin Time and Partial Thromboplastin Time (Revision of ICD-9-CM Codes for Swelling of Limb) Closed New
CAG-00331N PSA (Addition of ICD-9-CM 600.10, Nodular prostate without urinary obstruction and 600.11, with urinary obstruction, as covered indications) Closed New
Page 1 of 2
FirstPrev12NextLast
[62 Records]
MEDCAC Meetings
Page 1 of 3
FirstPrev123NextLast
Meeting Date
MEDCAC Title
09/15/1999 Autologous Stem Cell Transplantation (AuSCT) for Multiple Myeloma (Drugs, Biologics, and Therapeutics Panel)
11/15/1999 Human Tumor Assay Systems (Laboratory and Diagnostic Services Panel)
12/08/1999 Autologous Stem Cell Transplantation (AuSCT) for Multiple Myeloma & Human Tumor Assay Systems (Executive Committee)
03/01/2000 Executive Committee
04/12/2000 Urinary Incontinence (Medical and Surgical Procedures Panel)
06/06/2000 Urinary Incontinence (Executive Committee)
10/17/2000 Electrostimulation for Wounds (Medical and Surgical Procedures Panel)
10/18/2000 Sacral Nerve Stimulation for Urge Urinary Incontinence (Medical and Surgical Procedures Panel)
11/07/2000 Positron Emission Tomography (FDG) (Executive Committee)
02/21/2001 Ambulatory Blood Pressure Monitoring (Medical Devices and Prosthetics Panel)
02/22/2001 Electrostimulation for Wounds & Sacral Nerve Stimulation for Urge Urinary Incontinence (Executive Committee)
06/14/2001 Ambulatory Blood Pressure Monitoring (Executive Committee)
06/19/2001 Positron Emission Tomography (FDG) for Breast Cancer (Diagnostic Imaging Panel)
06/20/2001 Levocarnitine for End Stage Renal Disease (Drugs, Biologics, and Therapeutics Panel)
10/17/2001 Levocarnitine for End Stage Renal Disease & Positron Emission Tomography (FDG) for Breast Cancer (Executive Committee)
01/10/2002 Positron Emission Tomography (FDG) for Alzheimer's Disease/Dementia (Diagnostic Imaging Panel)
04/16/2002 Positron Emission Tomography (FDG) for Alzheimer's Disease/Dementia (Executive Committee)
06/12/2002 Deep Brain Stimulation for Parkinson's Disease (Medical and Surgical Procedures Panel)
09/25/2002 Deep Brain Stimulation for Parkinson's Disease (Executive Committee)
02/12/2003 Implantable Cardioverter Defibrillators
03/12/2003 Ventricular Assist Devices as Destination Therapy
09/09/2003 Ocular Photodynamic Therapy with Verteporfin for Macular Degeneration
07/14/2004 Transmyocardial revascularization (TMR) / Percutaneous Myocardial Revascularization (PMR)
09/28/2004 Continuous Positive Airway Pressure (CPAP) Therapy for Obstructive Sleep Apnea (OSA)
11/04/2004 Bariatric Surgery for Treatment of Morbid Obesity
Page 1 of 3
FirstPrev123NextLast
Technoloty Assessments (TAs)
Page 1 of 4
FirstPrev1234NextLast
TA Title

A Comparison of the Cost-Effectiveness of Fecal Occult Blood Tests with Different Test Characteristics in the Context of Annual Screening in the Medicare Population
A Horizon Scan: Uses of Hyperbaric Oxygen Therapy
A Proposed Framework to Evaluate Home Tests for Use in the Management of Chronic Diseases
A systematic review of loss-of-heterozygosity based topographic genotyping with PathfinderTG®
Actinic Keratoses: Final Report
Acupuncture for Fibromyalgia
Acupuncture for Osteoarthritis
Air-Fluidized Beds Used for Treatment of Pressure Ulcers in the Home Environment
Ambulatory Blood Pressure Monitoring For Adults With Elevated Office Blood Pressure
Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema
Applicability of the Evidence Regarding Intensive Glycemic Control and Self-Monitored Blood Glucose to Medicare Patients with Type 2 Diabetes
Assessment on Implantable Defibrillators and the Evidence for Primary Prevention of Sudden Cardiac Death
Bilateral Deep Brain Stimulation (Dbs) Of The Subthalamic Nucleus (Stn) Or The Globus Pallidus Interna (Gpi) For Treatment Of Advanced Parkinson's Disease
Biofeedback in the Treatment of Urinary Incontinence in Adults
Bone Morphogenetic Protein: The State of the Evidence of On-Label and Off-Label Use
Cardiac Catheterization in Freestanding Clinics
Comparative evaluation of radiation treatments for clinically localized prostate cancer: an update
Compendia for Coverage of Off-Label Uses of Drugs and Biologics in an Anticancer Chemotherapeutic Regimen
Consideration of Evidence on Antiemetic Drugs for Nausea and Vomiting Associated with Chemotherapy or Radiation Therapy in Adults
COST-EFFECTIVENESS OF CT COLONOGRAPHY TO SCREEN FOR COLORECTAL CANCER
COST-EFFECTIVENESS OF DNA STOOL TESTING TO SCREEN FOR COLORECTAL CANCER
Decompression Therapy for the Treatment of Lumbosacral Pain
Diagnosis and Treatment of Obesity In The Elderly
Diagnosis and Treatment of Secondary Lymphedema
ECG-based Signal Analysis Technologies
Page 1 of 4
FirstPrev1234NextLast
Medicare Coverage Documents (MCDs)
Page 1 of 1
MCD Type
MCD Title
Date Updated
Compendia AMA-DE Compendium Revision Request - CAG-00388 11/18/2013
Guidance Documents CED Public Solicitation 11/18/2013
Compendia Clinical Pharmacology Compendium Revision Request - CAG-00392 11/18/2013
Guidance Documents Draft Guidance for the Public, Industry, and CMS Staff Coverage with Evidence Development in the context of coverage decisions 11/18/2013
Guidance Documents Factors CMS Considers in Commissioning External Technology Assessments 11/18/2013
Guidance Documents Factors CMS Considers in Opening a National Coverage Determination 11/18/2013
Guidance Documents Factors CMS Considers in Referring Topics to the Medicare Evidence Development & Coverage Advisory Committee 11/18/2013
National Benefit Category Analyses INDEPENDENCE iBOT 4000 Mobility System: An Interactive Balancing Mobility System 11/18/2013
National Coverage Determinations Proposed for Removal List of National Coverage Determinations Proposed for Removal 11/27/2013
CMS Solicitation of Public Comments Medical Literature for Local Medicare Contractors to Determine Medically Accepted Indications for Drugs and Biologicals Used Anticancer Treatment 11/18/2013
CMS Solicitation of Public Comments Monitoring of Erythropoietin Stimulating Agents for Beneficiaries with End Stage Renal Disease 11/18/2013
Compendia NCCN Compendium Revision Request - CAG-00389 11/18/2013
Potential National Coverage Determination (NCD) Topics Potential NCD Topics 11/18/2013
National Benefit Category Analyses Reconstructive Treatments for Facial Lipodystrophy Syndrome 11/18/2013
Compendia Thomson Micromedex DrugDex ® Compendium Revision Request - CAG-00391 11/18/2013
Compendia Thomson Micromedex DrugPoints Compendium Revision Request - CAG-00390 11/18/2013
Page 1 of 1
27